Robust Salmonella metabolism limits possibilities for new antimicrobials.
about
Capnocytophaga canimorsus: a human pathogen feeding at the surface of epithelial cells and phagocytesFructose-asparagine is a primary nutrient during growth of Salmonella in the inflamed intestineConstraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interactionThe neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African childrenElucidating Host-Pathogen Interactions Based on Post-Translational Modifications Using Proteomics ApproachesNetwork-based approaches in drug discovery and early developmentMass spectrometry-based proteomic approaches to study pathogenic bacteria-host interactionsStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewModification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardiiIntraspecies competition for niches in the distal gut dictate transmission during persistent Salmonella infectionComprehensive assignment of roles for Salmonella typhimurium genes in intestinal colonization of food-producing animalsStructural Characterization of Inhibitors with Selectivity against Members of a Homologous Enzyme FamilyTetrahydrodipicolinate N-Succinyltransferase and Dihydrodipicolinate Synthase from Pseudomonas aeruginosa: Structure Analysis and Gene DeletionPurification and proteomics of pathogen-modified vacuoles and membranesSalmonella as a model for non-cognate Th1 cell stimulationCrystal structure of a type III pantothenate kinase: insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteriaSalmonella-induced mucosal lectin RegIIIβ kills competing gut microbiotaCore Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug TargetsIdentification of a common immune signature in murine and human systemic Salmonellosis.Mass spectrometry-based proteomics and its application to studies of Porphyromonas gingivalis invasion and pathogenicity.Integrated network reconstruction, visualization and analysis using YANAsquare.Inducing optimal substitution between antibiotics under open access to the resource of antibiotic susceptibility.Reconciling a Salmonella enterica metabolic model with experimental data confirms that overexpression of the glyoxylate shunt can rescue a lethal ppc deletion mutantA proteomic view of an important human pathogen--towards the quantification of the entire Staphylococcus aureus proteome.Integration of omics data: how well does it work for bacteria?Assessing the Metabolic Diversity of Streptococcus from a Protein Domain Point of View.Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.Three factors underlying incorrect in silico predictions of essential metabolic genesTransgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes.Histoplasma capsulatum proteome response to decreased iron availabilityIntegration of 'omics' data: does it lead to new insights into host-microbe interactions?Mass spectrometry-based quantitative proteomic analysis of Salmonella enterica serovar Enteritidis protein expression upon exposure to hydrogen peroxideIn vivo IFN-γ secretion by NK cells in response to Salmonella typhimurium requires NLRC4 inflammasomes.Postgenomic strategies in antibacterial drug discovery.Identification of metabolic pathways essential for fitness of Salmonella Typhimurium in vivo.Staphylococcus aureus physiological growth limitations: insights from flux calculations built on proteomics and external metabolite data.Isolation of F. novicida-Containing Phagosome from Infected Human Monocyte Derived Macrophages.Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children.Amino acid recognition and gene regulation by riboswitches.Complete proteome of a quinolone-resistant Salmonella Typhimurium phage type DT104B clinical strain.
P2860
Q21089623-937EF061-AD0D-48FC-BE0A-2BAA0D95C54DQ21131360-D0AC92B3-2838-4A1A-8812-DABDC9CB61BCQ24649162-46513558-62A2-438E-8FC8-82F3C76A9D1AQ24651695-FD1D85FD-7EBC-46C4-BACE-DBED10E82893Q26774700-F99FDE9C-E171-4F5F-A5FA-C867DB84F3D8Q26827940-E38CDAD0-FED8-4F07-8A46-6D3149F3A135Q26865681-5079957A-D130-416C-9716-10BB022E989DQ27008867-69472E28-87C0-4FC0-B8C7-BADE447BE66DQ27306197-01F36AD4-E062-4C4F-A12D-BDF8AB85E8B9Q27322699-78295BF8-1C23-4AFE-8DDA-5E91CD7447BBQ27323145-1A966DB9-C8DA-480B-ABC3-7E4C16DBDE82Q27675312-7FEFEA5B-E8C2-41BF-925C-03846A92BC9AQ27677435-C7B45CB4-F15E-41D1-980C-C6AB6361DCEFQ28080622-31430634-F65D-40F3-A291-0C8ADE9727A7Q28082931-1ADD9900-5C64-4BAB-A607-B2AC5A5894CFQ28252916-85F0993F-1AF1-43CB-A623-4CF0FD595869Q28504981-FFE49BF3-AB6C-4AA8-8861-FEE88BB9C64FQ28552763-E6A56255-ABB5-493B-B2D2-89AC73BE3A12Q30424877-6B2B729C-B26F-4D4A-A3F1-50C230803473Q30439892-A1108CB6-200D-49A4-9D6F-BC8AF84F6B62Q30480219-54E1CAD2-77CE-44B8-8B3D-41B559262695Q30489356-C00A424B-C935-42B7-86AA-9B5550870B3AQ30592724-94EAE9B8-804F-44AA-A1A6-97126A75758CQ30974252-337418F3-B186-41F4-8289-D413B479A7D2Q31066785-3866ED8C-D42B-496E-8BCF-AF08ED65679AQ33131299-DF0B4361-7F2D-4F7E-9E43-B51447C0D705Q33301096-FC9DA448-C569-4689-A147-181E1D846DE0Q33318131-1C83934B-3281-442E-84FC-D2179D4BCC2AQ33334019-2B01D320-416C-4721-B991-BB4FF90CDE0DQ33395856-BD6BE14C-784F-4FA3-BC1C-3164B7B6A7C1Q33530403-997631C2-6F2A-4357-8C8E-B36A57E101E4Q33597003-F08AD7C9-CCF1-4960-AD0F-F83E6C11EC6BQ33610279-FC3EDFDA-9D20-49C4-996F-F53677FA1334Q33745572-96E2E202-32CC-4E0F-8E8F-F8CA2E346D69Q33845728-EF05D0B2-F24F-4FA6-9A7F-67017BF4235BQ33864950-EFD5B799-F132-45B1-A807-41DC245E9B26Q33870965-C92B20F7-4436-47B1-B680-629E1C8E77EDQ33874236-B85BE8E1-AFFB-479C-BB63-40D246E94FDAQ34018578-7857AF2D-7520-4685-9263-0F58386FE94EQ34158566-EDF472FA-343D-4790-883D-0F361374F461
P2860
Robust Salmonella metabolism limits possibilities for new antimicrobials.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@ast
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@en
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@nl
type
label
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@ast
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@en
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@nl
prefLabel
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@ast
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@en
Robust Salmonella metabolism limits possibilities for new antimicrobials.
@nl
P2093
P356
P1433
P1476
Robust Salmonella metabolism limits possibilities for new antimicrobials
@en
P2093
Claudia Rollenhagen
Daniel Becker
Dirk Bumann
Matthias Ballmaier
Matthias Mann
Matthias Selbach
P2888
P304
P356
10.1038/NATURE04616
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1040351681